Health SaaS company trading on a PE of 7.7
Market Cap $7.4m, Net Cash $0.5m.
Global Health is a high margin / high ROCE recurring income business with a software portfolio well suited for the evolving demands of global hospital and community healthcare providers. The company is transitioning from its position as an Australian specialist player towards a SaaS/consumer-focused international model. The long term value creation potential is significant with numerous business catalysts coming in the next 2-3 years.
Management are forecasting reasonable EPS growth for 2016 and with a recent $3m contract win, and further contracts expected there may well be room for further upgrades. A large proportion of revenue is reccuring and the company is materially undervalued at current prices.
__________________________________________
____________________________________________
